Sagimet Biosciences Cash from Financing (TTM) Insights

Sagimet Biosciences Inc (SGMT)

4.32 -0.13 (-2.92%) USD | NASDAQ | May 03, 16:00

4.32 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2022. Upgrade now.

Date	Value
December 31, 2023	86.17M
September 30, 2023	86.11M
June 30, 2023	-1.101M
March 31, 2023	-0.221M

Date	Value
December 31, 2022	-0.073M
September 30, 2022	11.13M
June 30, 2022	11.13M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.101M

Minimum

Jun 2023

86.17M

Maximum

Dec 2023

27.59M

Average

11.13M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks